93 related articles for article (PubMed ID: 26944485)
21. Regulation of JAK2 protein expression by chronic, pulsatile GH administration in vivo: a possible mechanism for ligand enhancement of signal transduction.
Zhou Y; Wang X; Hadley J; Corey SJ; Vasilatos-Younken R
Gen Comp Endocrinol; 2005 Nov; 144(2):128-39. PubMed ID: 15993410
[TBL] [Abstract][Full Text] [Related]
22. Insulin receptor substrate-1-mediated enhancement of growth hormone-induced mitogen-activated protein kinase activation.
Liang L; Jiang J; Frank SJ
Endocrinology; 2000 Sep; 141(9):3328-36. PubMed ID: 10965905
[TBL] [Abstract][Full Text] [Related]
23. Increased site 1 affinity improves biopotency of porcine growth hormone. Evidence against diffusion dependent receptor dimerization.
Wan Y; McDevitt A; Shen B; Smythe ML; Waters MJ
J Biol Chem; 2004 Oct; 279(43):44775-84. PubMed ID: 15297460
[TBL] [Abstract][Full Text] [Related]
24. The Cellular Behavior, Intracellular Signaling Profile and Nuclear-Targeted Potential Functions of Porcine Growth Hormone (pGH) in Swine Testicular Cells.
Zhang Y; Zhao Q; Wu D; Li S; Wu M; Li S; Zheng X; Lan H
Cell Biochem Biophys; 2022 Jun; 80(2):403-414. PubMed ID: 35171434
[TBL] [Abstract][Full Text] [Related]
25. Clinical pharmacology of human growth hormone and its secretagogues.
Root AW; Root MJ
Curr Drug Targets Immune Endocr Metabol Disord; 2002 Apr; 2(1):27-52. PubMed ID: 12477295
[TBL] [Abstract][Full Text] [Related]
26. Growth hormone-regulated intracellular signaling in UMR 106 osteosarcoma cells.
Morales O; Lindgren U; Haldosén LA
J Bone Miner Res; 2000 Nov; 15(11):2284-90. PubMed ID: 11092411
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
28. Identification of growth hormone receptor (GHR) tyrosine residues required for GHR phosphorylation and JAK2 and STAT5 activation.
Wang X; Darus CJ; Xu BC; Kopchick JJ
Mol Endocrinol; 1996 Oct; 10(10):1249-60. PubMed ID: 9121492
[TBL] [Abstract][Full Text] [Related]
29. Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems.
Rowlinson SW; Waters MJ; Lewis UJ; Barnard R
Endocrinology; 1996 Jan; 137(1):90-5. PubMed ID: 8536647
[TBL] [Abstract][Full Text] [Related]
30. Regulation of glucose transport and c-fos and egr-1 expression in cells with mutated or endogenous growth hormone receptors.
Gong TW; Meyer DJ; Liao J; Hodge CL; Campbell GS; Wang X; Billestrup N; Carter-Su C; Schwartz J
Endocrinology; 1998 Apr; 139(4):1863-71. PubMed ID: 9528972
[TBL] [Abstract][Full Text] [Related]
31. Characterization of growth hormone-induced tyrosine-phosphorylated proteins in mouse cells that express GH receptors.
Xu BC; Wang X; James C; Kopchick JJ
Receptor; 1995; 5(2):105-16. PubMed ID: 7580936
[TBL] [Abstract][Full Text] [Related]
32. Demonstration of growth hormone (GH) receptor-associated tyrosine kinase activity in multiple GH-responsive cell types.
Stred SE; Stubbart JR; Argetsinger LS; Shafer JA; Carter-Su C
Endocrinology; 1990 Nov; 127(5):2506-16. PubMed ID: 2171917
[TBL] [Abstract][Full Text] [Related]
33. SOCS-3 is involved in the downregulation of the acute insulin-like effects of growth hormone in rat adipocytes by inhibition of Jak2/IRS-1 signaling.
Ridderstråle M; Amstrup J; Hilton DJ; Billestrup N; Tornqvist H
Horm Metab Res; 2003 Mar; 35(3):169-77. PubMed ID: 12734778
[TBL] [Abstract][Full Text] [Related]
34. Desensitization of the growth hormone-induced Janus kinase 2 (Jak 2)/signal transducer and activator of transcription 5 (Stat5)-signaling pathway requires protein synthesis and phospholipase C.
Fernández L; Flores-Morales A; Lahuna O; Sliva D; Norstedt G; Haldosén LA; Mode A; Gustafsson JA
Endocrinology; 1998 Apr; 139(4):1815-24. PubMed ID: 9528967
[TBL] [Abstract][Full Text] [Related]
35. Differential intracellular signalling properties of the growth hormone receptor induced by the activation of an anti-GHR antibody.
Lan H; Li W; Fu Z; Yang Y; Wu T; Liu Y; Zhang H; Cui H; Li Y; Hong P; Liu J; Zheng X
Mol Cell Endocrinol; 2014 Jun; 390(1-2):54-64. PubMed ID: 24755421
[TBL] [Abstract][Full Text] [Related]
36. Assay of pig growth hormone preparations for metabolic activities in the rat and in man.
Mills JB; Zeringue M; Harris R; Wilhelmi AE; Rudman D
J Clin Endocrinol Metab; 1976 Jun; 42(6):1127-32. PubMed ID: 132455
[TBL] [Abstract][Full Text] [Related]
37. Chronic uremia attenuates growth hormone-induced signal transduction in skeletal muscle.
Sun DF; Zheng Z; Tummala P; Oh J; Schaefer F; Rabkin R
J Am Soc Nephrol; 2004 Oct; 15(10):2630-6. PubMed ID: 15466267
[TBL] [Abstract][Full Text] [Related]
38. Growth hormone-induced reorganization of the actin cytoskeleton is not required for STAT5 (signal transducer and activator of transcription-5)-mediated transcription.
Goh EL; Pircher TJ; Wood TJ; Norstedt G; Graichen R; Lobie PE
Endocrinology; 1997 Aug; 138(8):3207-15. PubMed ID: 9231769
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone (GH)-stimulated insulin-like growth factor I gene expression is mediated by a tyrosine phosphorylation pathway depending on C-terminal region of human GH receptor in human GH receptor-expressing Ba/F3 cells.
Yoshizato H; Tanaka M; Nakai N; Nakao N; Nakashima K
Endocrinology; 2004 Jan; 145(1):214-20. PubMed ID: 14551225
[TBL] [Abstract][Full Text] [Related]
40. Suppression of growth hormone (GH) Janus tyrosine kinase 2/signal transducer and activator of transcription 5 signaling pathway in transgenic mice overexpressing bovine GH.
Miquet JG; Sotelo AI; Bartke A; Turyn D
Endocrinology; 2004 Jun; 145(6):2824-32. PubMed ID: 15016718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
